Emrah Acar
Latest contributions
New platforms for coronary lesions treatment
21 May 2026 – From EuroPCR 2026
Delve into the latest developments in coronary lesion treatment platforms through this session, highlighting real-world performance data of novel drug-eluting stents like Eternia and Evermine 50. It also presents preclinical insights on biomimetic CD31-coated stents, long-term outcomes of the Fantom BRS platform, and innovative randomized trials...
Selecting PCI devices in specific scenarios
19 May 2026 – From EuroPCR 2026
This session addresses device selection strategies tailored to specific interventional cardiology scenarios. It covers innovative approaches such as coronary laser use in difficult lesions, intravascular imaging-guided treatments for in-stent restenosis, and physiological assessment post-magnesium scaffold resorption, supported by real-world data and emerging machine learning applications.